These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26431249)

  • 1. Insulin analogues in pregnancy and specific congenital anomalies: a literature review.
    de Jong J; Garne E; Wender-Ozegowska E; Morgan M; de Jong-van den Berg LT; Wang H
    Diabetes Metab Res Rev; 2016 May; 32(4):366-75. PubMed ID: 26431249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy.
    Wyatt JW; Frias JL; Hoyme HE; Jovanovic L; Kaaja R; Brown F; Garg S; Lee-Parritz A; Seely EW; Kerr L; Mattoo V; Tan M;
    Diabet Med; 2005 Jun; 22(6):803-7. PubMed ID: 15910635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis.
    Singh SR; Ahmad F; Lal A; Yu C; Bai Z; Bennett H
    CMAJ; 2009 Feb; 180(4):385-97. PubMed ID: 19221352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin analogues use in pregnancy among women with pregestational diabetes mellitus and risk of congenital anomaly: a retrospective population-based cohort study.
    Wang H; Wender-Ozegowska E; Garne E; Morgan M; Loane M; Morris JK; Bakker MK; Gatt M; de Walle H; Jordan S; Materna-Kiryluk A; Nelen V; Thys G; Wiesel A; Dolk H; de Jong-van den Berg LTW
    BMJ Open; 2018 Feb; 8(2):e014972. PubMed ID: 29478010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is insulin lispro safe in pregnant women: Does it cause any adverse outcomes on infants or mothers?
    Aydin Y; Berker D; Direktör N; Ustün I; Tütüncü YA; Işik S; Delibaşi T; Guler S
    Diabetes Res Clin Pract; 2008 Jun; 80(3):444-8. PubMed ID: 18359121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of insulin analogues as compared with human insulin in pregnancy.
    Toledano Y; Hadar E; Hod M
    Expert Opin Drug Saf; 2016 Jul; 15(7):963-73. PubMed ID: 27145344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal insulin analogues in the management of diabetes mellitus: What progress have we made?
    Owens DR; Matfin G; Monnier L
    Diabetes Metab Res Rev; 2014 Feb; 30(2):104-19. PubMed ID: 24026961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Different Insulin Therapies on Obstetric-Fetal Outcomes.
    López-Tinoco C; Jiménez-Blázquez JL; Larrán-Escandón L; Roca-Rodríguez MDM; Bugatto F; Aguilar-Diosdado M
    Sci Rep; 2019 Nov; 9(1):17650. PubMed ID: 31776421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin glulisine: efficacy and safety compared with other rapid-acting insulin analogues.
    Kamal AD; Bain SC
    Expert Opin Drug Saf; 2007 Jan; 6(1):5-7. PubMed ID: 17181446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin glargine compared with Neutral Protamine Hagedorn insulin in the treatment of pregnant diabetics.
    Fang YM; MacKeen D; Egan JF; Zelop CM
    J Matern Fetal Neonatal Med; 2009 Mar; 22(3):249-53. PubMed ID: 19330710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perinatal outcomes in pregnancies managed with antenatal insulin glargine.
    Egerman RS; Ramsey RD; Kao LW; Bringman JJ; Haerian H; Kao JL; Bush AJ
    Am J Perinatol; 2009 Sep; 26(8):591-5. PubMed ID: 19370512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel insulin analogues and its mitogenic potential.
    Zib I; Raskin P
    Diabetes Obes Metab; 2006 Nov; 8(6):611-20. PubMed ID: 17026485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trial.
    Pedersen-Bjergaard U; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Christiansen JS; Jensen T; Hougaard P; Parving HH; Thorsteinsson B; Tarnow L
    Lancet Diabetes Endocrinol; 2014 Jul; 2(7):553-61. PubMed ID: 24794703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Insulin analogues: modifications in the structure, molecular and metabolic consequences].
    de Luis DA; Romero E
    Semergen; 2013; 39(1):34-40. PubMed ID: 23517895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on insulin analogues.
    Drug Ther Bull; 2004 Oct; 42(10):77-80. PubMed ID: 15491022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin analogues in the management of the pregnancy complicated by diabetes mellitus.
    Durnwald CP; Landon MB
    Curr Diab Rep; 2011 Feb; 11(1):28-34. PubMed ID: 21072620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin analogues in the management of diabetes.
    Vázquez-Carrera M; Silvestre JS
    Methods Find Exp Clin Pharmacol; 2004; 26(6):445-61. PubMed ID: 15349139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoatrophy associated with the use of insulin analogues: a new case associated with the use of insulin glargine and review of the literature.
    Holstein A; Stege H; Kovacs P
    Expert Opin Drug Saf; 2010 Mar; 9(2):225-31. PubMed ID: 20001763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
    Baxter MA
    Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.